At the start of this year we had a stakeholder seminar (described here). The academics participating in the meeting took an extra day to bring together the learning from the different stories we heard from all the other actors participating from Spain and Norway. As a result of this, we developed a policy brief on the potential of a politics of care for advancing good governance of biotechnology. In this policy brief, we briefly describe the different elements of importance for care ethics and politics and how these can be usefully used to guide socio-economic and ethical assessment of genetically modified organisms. This included a set of guiding questions to ask during the assessment process.
Guiding Questions to Advance a Politics of Care in Biotechnology Governance